Disc Medicine to Participate in Upcoming Investor Conferences
Disc Medicine (NASDAQ:IRON), a clinical-stage biopharmaceutical company specializing in treatments for hematologic diseases, has announced its participation in two major investor conferences. The company's management will engage in fireside chats at the Jefferies Global Healthcare Conference on June 5th at 10:30 a.m. ET and the Goldman Sachs 46th Annual Global Healthcare Conference on June 9th at 1:20 p.m. ET. Both sessions will be accessible via live webcast through Disc Medicine's investor relations website, with archived replays available post-event.
Disc Medicine (NASDAQ:IRON), un'azienda biofarmaceutica in fase clinica specializzata in trattamenti per le malattie ematologiche, ha annunciato la sua partecipazione a due importanti conferenze per investitori. Il management della società parteciperà a discussioni informali al Jefferies Global Healthcare Conference il 5 giugno alle 10:30 ET e al Goldman Sachs 46th Annual Global Healthcare Conference il 9 giugno alle 13:20 ET. Entrambe le sessioni saranno accessibili in diretta streaming tramite il sito web delle relazioni con gli investitori di Disc Medicine, con repliche archiviate disponibili dopo l'evento.
Disc Medicine (NASDAQ:IRON), una empresa biofarmacéutica en etapa clínica especializada en tratamientos para enfermedades hematológicas, ha anunciado su participación en dos importantes conferencias para inversores. La dirección de la compañía participará en charlas informales en la Jefferies Global Healthcare Conference el 5 de junio a las 10:30 a.m. ET y en la Goldman Sachs 46th Annual Global Healthcare Conference el 9 de junio a la 1:20 p.m. ET. Ambas sesiones estarán disponibles en transmisión en vivo a través del sitio web de relaciones con inversores de Disc Medicine, con repeticiones archivadas disponibles después del evento.
Disc Medicine (NASDAQ:IRON)은 혈액 질환 치료에 특화된 임상 단계 바이오제약 회사로서, 두 개의 주요 투자자 컨퍼런스에 참여한다고 발표했습니다. 회사 경영진은 Jefferies Global Healthcare Conference에서 6월 5일 오전 10시 30분(동부시간)에, Goldman Sachs 46th Annual Global Healthcare Conference에서 6월 9일 오후 1시 20분(동부시간)에 파이어사이드 채팅에 참여할 예정입니다. 두 세션 모두 Disc Medicine 투자자 관계 웹사이트를 통해 생중계로 시청할 수 있으며, 행사 후에는 녹화 재생도 제공됩니다.
Disc Medicine (NASDAQ:IRON), une société biopharmaceutique en phase clinique spécialisée dans les traitements des maladies hématologiques, a annoncé sa participation à deux grandes conférences pour investisseurs. La direction de l'entreprise participera à des discussions informelles lors du Jefferies Global Healthcare Conference le 5 juin à 10h30 ET et du Goldman Sachs 46th Annual Global Healthcare Conference le 9 juin à 13h20 ET. Les deux sessions seront accessibles en webcast en direct via le site des relations investisseurs de Disc Medicine, avec des rediffusions archivées disponibles après l'événement.
Disc Medicine (NASDAQ:IRON), ein biopharmazeutisches Unternehmen in der klinischen Entwicklungsphase, das sich auf die Behandlung hämatologischer Erkrankungen spezialisiert hat, hat seine Teilnahme an zwei bedeutenden Investorenkonferenzen angekündigt. Das Management des Unternehmens wird am Jefferies Global Healthcare Conference am 5. Juni um 10:30 Uhr ET und am Goldman Sachs 46th Annual Global Healthcare Conference am 9. Juni um 13:20 Uhr ET an Fireside Chats teilnehmen. Beide Sitzungen sind über einen Live-Webcast auf der Investor-Relations-Website von Disc Medicine zugänglich, mit archivierten Wiedergaben, die nach der Veranstaltung verfügbar sind.
- None.
- None.
WATERTOWN, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will participate in fireside chats at two upcoming investor conferences:
- Jefferies Global Healthcare Conference on Thursday, June 5th at 10:30 a.m. ET.
- Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9th at 1:20 p.m. ET.
Live webcasts of the fireside chats will be available through the investor relations section of the Company's website at ir.discmedicine.com and an archived replay will be available after the event.
About Disc Medicine
Disc Medicine (NASDAQ:IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. For more information, please visit www.discmedicine.com.
Media Contact
Peg Rusconi
Deerfield Group
peg.rusconi@deerfieldgroup.com
Investor Relations Contact
Christina Tartaglia
Precision AQ
christina.tartaglia@precisionaq.com
FAQ
When is Disc Medicine (IRON) presenting at the Jefferies Global Healthcare Conference 2025?
What time is IRON's presentation at the Goldman Sachs Healthcare Conference 2025?
How can investors watch Disc Medicine's (IRON) conference presentations?
What is Disc Medicine's (IRON) main business focus?
